Department of General Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 17 Yongwaizheng Street, Nanchang, Jiangxi Province, 330006, China.
World J Surg Oncol. 2024 Sep 4;22(1):230. doi: 10.1186/s12957-024-03484-5.
Totally robotic distal gastrectomy (TRDG) is being used more and more in gastric cancer (GC) patients. The study aims to evaluate the short-term efficacy of TRDG and robotic-assisted distal gastrectomy (RADG) in the treatment of GC.
We retrospectively collected the clinical data of patients who underwent TRDG or RADG, of which 60 patients were included in the study: 30 cases of totally robotic and 30 cases of robotic-assisted. The short-term efficacy of the two groups was compared.
There was no significant difference in the clinicopathological data between the two groups. Compared to RADG, TRDG had less intraoperative blood loss(P = 0.019), less postoperative abdominal drainage(P = 0.031), shorter time of exhaust( P = 0.001) and liquid diet(P = 0.001), shorter length of incision(P<0.01), shorter postoperative hospital stays(P = 0.033), lower postoperative C-reactive protein(CRP)(P = 0.024) and lower postoperative Visual Analogue Scale(VAS) scores(P = 0.048). However, no significant statistical differences were found in terms of total operation time(P = 0.108), number of lymph nodes retrieved(P = 0.307), time for anastomosis(P = 0.450), proximal resection margin(P = 0.210), distal resection margin(P = 0.202), postoperative complication(P = 0.506), total hospital cost(P = 0.286) and postoperative white blood cell(WBC)(P = 0.113).
In terms of security and technology, TRDG could serve as a better treatment method for GC.
全机器人辅助远端胃切除术（TRDG）在胃癌（GC）患者中应用越来越多。本研究旨在评估 TRDG 和机器人辅助远端胃切除术（RADG）治疗 GC 的短期疗效。
我们回顾性收集了接受 TRDG 或 RADG 的患者的临床资料，其中 60 例患者纳入研究：30 例全机器人组和 30 例机器人辅助组。比较两组的短期疗效。
两组患者的临床病理资料无显著差异。与 RADG 相比，TRDG 术中出血量更少（P=0.019），术后腹腔引流更少（P=0.031），排气时间更短（P=0.001）和开始进液时间更短（P=0.001），切口长度更短（P<0.01），术后住院时间更短（P=0.033），术后 C 反应蛋白（CRP）更低（P=0.024），术后视觉模拟评分（VAS）评分更低（P=0.048）。但总手术时间（P=0.108）、淋巴结检出数（P=0.307）、吻合时间（P=0.450）、近端切缘（P=0.210）、远端切缘（P=0.202）、术后并发症（P=0.506）、总住院费用（P=0.286）和术后白细胞（WBC）计数（P=0.113）差异均无统计学意义。
就安全性和技术而言，TRDG 可以作为 GC 的一种更好的治疗方法。
